Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,257 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $944.07 | 46 | $0 (2024) |
| Novo Nordisk Inc | $57.37 | 3 | $0 (2019) |
| Astellas Pharma US Inc | $41.86 | 2 | $0 (2018) |
| PFIZER INC. | $37.20 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $32.61 | 2 | $0 (2019) |
| Philips Electronics North America Corporation | $31.31 | 1 | $0 (2018) |
| Upsher-Smith Laboratories LLC | $29.94 | 2 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.48 | 2 | $0 (2018) |
| Boston Scientific Corporation | $18.37 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $16.42 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.46 | 12 | ABBVIE INC. ($288.46) |
| 2023 | $230.21 | 11 | ABBVIE INC. ($230.21) |
| 2022 | $154.52 | 9 | ABBVIE INC. ($154.52) |
| 2021 | $270.88 | 14 | AbbVie Inc. ($270.88) |
| 2020 | $29.94 | 2 | Upsher-Smith Laboratories LLC ($29.94) |
| 2019 | $78.62 | 5 | Novo Nordisk Inc ($34.72) |
| 2018 | $134.72 | 7 | Astellas Pharma US Inc ($41.86) |
| 2017 | $70.10 | 5 | PFIZER INC. ($37.20) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 282 | 326 | $73,203 | $17,780 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 85 | $25,330 | $5,438 | 21.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 136 | $27,336 | $5,202 | 19.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 20 | 20 | $4,660 | $2,397 | 51.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 28 | 28 | $11,200 | $2,306 | 20.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 30 | 30 | $3,840 | $2,180 | 56.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $492.00 | $208.48 | 42.4% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 13 | 15 | $345.00 | $47.31 | 13.7% |
About Dr. David Farley, M.D
Dr. David Farley, M.D is a Family Medicine healthcare provider based in West Linn, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518982636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Farley, M.D has received a total of $1,257 in payments from pharmaceutical and medical device companies, with $288.46 received in 2024. These payments were reported across 65 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,257).
As a Medicare-enrolled provider, Farley has provided services to 282 Medicare beneficiaries, totaling 326 services with total Medicare billing of $17,780. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location West Linn, OR
- Active Since 07/12/2006
- Last Updated 12/04/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518982636
Products in Payments
- UBRELVY (Drug) $514.87
- QULIPTA (Drug) $380.89
- VRAYLAR (Drug) $48.31
- VIAGRA (Drug) $37.20
- Respiratoriy Care Undiv (Device) $31.31
- ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION (Drug) $29.94
- Victoza (Drug) $22.65
- Trintellix (Drug) $22.48
- Tresiba (Drug) $21.42
- MYRBETRIQ (Drug) $20.93
- VESICARE (Drug) $20.93
- JETSTREAM (Device) $18.37
- ELIQUIS (Drug) $16.42
- TOUJEO (Drug) $14.90
- JANUVIA (Drug) $14.61
- Ozempic (Drug) $13.30
- Mitigare (Drug) $10.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Linn
Dr. Ryan Scott, M.d, M.D
Family Medicine — Payments: $9,796
Dr. Joyce Endo, M.d, M.D
Family Medicine — Payments: $1,539
Dr. Lawrence Tremaine, Do, DO
Family Medicine — Payments: $842.35
Dr. Laurens Johansen, Md, MD
Family Medicine — Payments: $45.36
Dr. Ronald Powell, D.o, D.O
Family Medicine
Robert Wagner, Md, MD
Family Medicine